Speakers
Andrew joined the Firm in 2024 from Raymond James & Associates where he most recently served as a Senior Managing Director and Vice Chairman in…
Read More
Peter K. Kaiser, MD graduated magna cum laude with Highest Honors from Harvard College and Harvard Medical School. He completed an ophthalmology residency at the…
Read More
Dr. David Boyer is a world-renowned clinician, surgeon, and educator. He received a Bachelor of Science Degree from the University of Illinois at Champaign, IL,…
Read More
Dr Sophia Pathai is a member of the investment team at Peppermint VenturePartners GmBH, a private venture capital firm headquartered in Berlin, Germany. She…
Read More
Shamika Gune MD is a Group Medical Director at Genentech. She is a vitreoretinal surgeon now fully dedicated to industry and research. Prior to Genentech,…
Read More
Paul Bresge has been a leader in the cell and gene therapy biotech space for over a decade. He is co-founder and Chief Executive Officer…
Read More
David is an experienced healthcare executive who has built and scaled multiple companies that resulted in successful exits to strategic buyers. David is currently the…
Read More
Jerry is a managing director in the Global Healthcare Group. He joined Goldman Sachs in 2007 as an associate, was named managing director in 2015…
Read More
WORK EXPERIENCE CEO, DUTCH OPHTHALMIC R.C. BV, THE NETHERLANDS Jun 2020 – To date PRESIDENT & CEO, HUMANOPTICS AG, GERMANY Jan 2017 – Apr 2020…
Read More
Nancy M. Holekamp, MD is Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri. Prior, she was Professor of Clinical Ophthalmology…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")